Visual Acuity, Vitreous Hemorrhage, and Other Ocular Outcomes After Vitrectomy vs Aflibercept for Vitreous Hemorrhage Due to Diabetic Retinopathy: A Secondary Analysis of a Randomized Clinical Trial

IMPORTANCE: Although there were no differences in mean visual acuity (VA) over 24 weeks after vitrectomy with panretinal photocoagulation (PRP) vs aflibercept in a randomized clinical trial among eyes with vitreous hemorrhage due to proliferative diabetic retinopathy (PDR), post hoc analyses may inf...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:JAMA Ophthalmol
Autori principali: Glassman, Adam R., Beaulieu, Wesley T., Maguire, Maureen G., Antoszyk, Andrew N., Chow, Clement C., Elman, Michael J., Jampol, Lee M., Salehi-Had, Hani, Sun, Jennifer K.
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Medical Association 2021
Soggetti:
Original Investigation
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8295737/
https://ncbi.nlm.nih.gov/pubmed/33956075
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaophthalmol.2021.1110
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi